FIELD: medicine.
SUBSTANCE: method involves determining anti-inflammatory cytokines IL-1β and TNF-α and anti-inflammatory IL-4 content. K coefficient is calculated from formula K=(ln IL-1β + ln TNF-α)/ ln IL-4. K value being found greater than 2, recurrent clinical course of diffuse toxic goiter is to be predicted.
EFFECT: high prognosis accuracy.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRE-OPERATIVE DETECTION OF OPERATION EXTENT IN PATIENTS WITH DIFFUSE TOXIC GOITER | 2014 |
|
RU2557946C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF RELAPSE IN THE MEDICAL TREATMENT OF GRAVES' DISEASE | 2021 |
|
RU2778614C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF DIFFERENT AUTOIMMUNE THYROID LESIONS | 2006 |
|
RU2315322C1 |
| METHOD FOR SURGICAL TREATMENT OF THYROID CANCER IN THYROTOXICOSIS | 2020 |
|
RU2751971C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF ENDOCRINE OPHTHALMOPATHY IN PATIENTS WITH GRAVES DISEASE BY DETECTING ANTI-THYROID PEROXIDASE ANTIBODIES | 2011 |
|
RU2460072C1 |
| METHOD FOR DIFFUSE TOXIC GOITER COMPLEX TREATMENT | 2016 |
|
RU2614850C1 |
| METHOD FOR PREDICTING RADIOIODINE THERAPY FOR GRAVES' DISEASE | 2022 |
|
RU2791390C1 |
| METHOD FOR EARLY DIAGNOSIS OF AN ACTIVE PHASE OF ENDOCRINE OPHTHALMOPATHY | 2018 |
|
RU2687082C1 |
| METHOD FOR PERSONALIZED APPROACH TO CHOOSING METHOD FOR TREATMENT OF GRAVES DISEASE | 2022 |
|
RU2794815C1 |
| METHOD OF TREATING DIFFUSE TOXIC GOITER | 1992 |
|
RU2028103C1 |
